Skip to main content
. Author manuscript; available in PMC: 2017 Nov 29.
Published in final edited form as: Circulation. 2016 Sep 29;134(22):1738–1748. doi: 10.1161/CIRCULATIONAHA.115.020086

Figure 3.

Figure 3

A. SERCA uptake velocity measured by 45Ca SERCA uptake assay (control n=6, MYBPC3-mutation HCM n=7, MYH7-mutation HCM n=3, sarcomere-negative HCM n=5). B. Normalized SERCA uptake velocity. C. Total SERCA uptake measured by 45Ca SERCA uptake assay as maximum (saturating) uptake after one hour incubation. D. Normalized total SERCA uptake measured by 45Ca SERCA uptake assay as maximum (saturating) uptake after one hour incubation. *p<0.05 for all HCM groups vs control.